7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.18103/mra.v12i10.5958
Copy DOIJournal: Medical Research Archives | Publication Date: Jan 1, 2024 |
Although there are multiple risk factors for obstructive sleep apnea, obesity is a significant actionable risk factor that is increasing worldwide. Studies have shown that weight loss whether through bariatric surgery or medications is associated with improvement in obstructive sleep apnea severity. This review summarizes the underlying mechanisms of glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonists pertaining to weight loss and then summarizes the studies which show beneficial effects on weight loss in obese adults with or without diabetes. We then review the available studies showing a reduction in obstructive sleep apnea severity in adult patients with obesity primarily through weight reduction. Potential limitations and implications of treatment with these medications for obstructive sleep apnea will be reviewed.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.